Literature DB >> 22685317

Breakdown in repression of IFN-γ mRNA leads to accumulation of self-reactive effector CD8+ T cells.

Pheh-Ping Chang1, Sau K Lee, Xin Hu, Gayle Davey, Guowen Duan, Jae-Ho Cho, Guna Karupiah, Jonathan Sprent, William R Heath, Edward M Bertram, Carola G Vinuesa.   

Abstract

Tight regulation of virus-induced cytotoxic effector CD8(+) T cells is essential to prevent immunopathology. Naturally occurring effector CD8(+) T cells, with a KLRG1(hi) CD62L(lo) phenotype typical of short-lived effector CD8(+) T cells (SLECs), can be found in increased numbers in autoimmune-prone mice, most notably in mice homozygous for the san allele of Roquin. These SLEC-like cells were able to trigger autoimmune diabetes in a susceptible background. When Roquin is mutated (Roquin(san)), effector CD8(+) T cells accumulate in a cell-autonomous manner, most prominently as SLEC-like effectors. Excessive IFN-γ promotes the accumulation of SLEC-like cells, increases their T-bet expression, and enhances their granzyme B production in vivo. We show that overexpression of IFN-γ was caused by failed posttranscriptional repression of Ifng mRNA. This study identifies a novel mechanism that prevents accumulation of self-reactive cytotoxic effectors, highlighting the importance of regulating Ifng mRNA stability to maintain CD8(+) T cell homeostasis and prevent CD8-mediated autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22685317     DOI: 10.4049/jimmunol.1102432

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.

Authors:  Wenting Huang; Kritika Kachapati; David Adams; Yuehong Wu; Patrick S C Leung; Guo-Xiang Yang; Weici Zhang; Aftab A Ansari; Richard A Flavell; M Eric Gershwin; William M Ridgway
Journal:  J Autoimmun       Date:  2014-02-18       Impact factor: 7.094

2.  Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition.

Authors:  Tamika L Payne; Jeff Blackinton; Alyse Frisbee; Joy Pickeral; Sheetal Sawant; Nathan A Vandergrift; Stephanie A Freel; Guido Ferrari; Jack D Keene; Georgia D Tomaras
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

3.  CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion.

Authors:  Marie-Clare St Rose; Roslyn A Taylor; Suman Bandyopadhyay; Harry Z Qui; Adam T Hagymasi; Anthony T Vella; Adam J Adler
Journal:  Immunol Cell Biol       Date:  2013-01-08       Impact factor: 5.126

Review 4.  Post-transcriptional control of T-cell cytokine production: Implications for cancer therapy.

Authors:  Julian J Freen-van Heeren
Journal:  Immunology       Date:  2021-05-10       Impact factor: 7.215

Review 5.  Using CRISPR to enhance T cell effector function for therapeutic applications.

Authors:  Julian J Freen-van Heeren
Journal:  Cytokine X       Date:  2020-12-21

6.  The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins.

Authors:  Georg Petkau; Twm J Mitchell; Krishnendu Chakraborty; Sarah E Bell; Vanessa D Angeli; Louise Matheson; David J Turner; Alexander Saveliev; Ozge Gizlenci; Fiamma Salerno; Peter D Katsikis; Martin Turner
Journal:  Nat Commun       Date:  2022-04-27       Impact factor: 17.694

7.  Small intestine inflammation in Roquin-mutant and Roquin-deficient mice.

Authors:  Jeremy S Schaefer; Dina Montufar-Solis; Niyati Nakra; Nadarajah Vigneswaran; John R Klein
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

8.  Attenuation of AMPK signaling by ROQUIN promotes T follicular helper cell formation.

Authors:  Roybel R Ramiscal; Ian A Parish; Robert S Lee-Young; Jeffrey J Babon; Julianna Blagih; Alvin Pratama; Jaime Martin; Naomi Hawley; Jean Y Cappello; Pablo F Nieto; Julia I Ellyard; Nadia J Kershaw; Rebecca A Sweet; Christopher C Goodnow; Russell G Jones; Mark A Febbraio; Carola G Vinuesa; Vicki Athanasopoulos
Journal:  Elife       Date:  2015-10-23       Impact factor: 8.140

9.  iNKT Cells Suppress Pathogenic NK1.1+CD8+ T Cells in DSS-Induced Colitis.

Authors:  Sung Won Lee; Hyun Jung Park; Jae Hee Cheon; Lan Wu; Luc Van Kaer; Seokmann Hong
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.